Unlock instant, AI-driven research and patent intelligence for your innovation.

A composition containing cyclic adenosine monophosphate and its application

A technology containing cyclic adenosine monophosphate and cyclic adenosine monophosphate, which is applied in the development of drugs for the treatment of myocardial infarction, and in the field of compositions containing cyclic adenosine monophosphate, which can solve problems such as diphenhydramine and vinpocetine myocardial infarction that have not yet been seen , to achieve good myocardial infarction effect

Active Publication Date: 2016-01-20
GUANGZHOU YIPINHONG PHARMA +4
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] At present, there is no relevant research on the use of diphenhydramine and vinpocetine in the treatment of myocardial infarction, and there is no relevant study on the use of diphenhydramine, vinpocetine and niacin in combination with cyclic adenosine monophosphate in the treatment of myocardial infarction. research report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A composition containing cyclic adenosine monophosphate and its application
  • A composition containing cyclic adenosine monophosphate and its application
  • A composition containing cyclic adenosine monophosphate and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] The composition containing cyclic adenosine monophosphate of the present invention, the formula of this composition is made up of each component of following parts by weight:

[0025]

[0026] The preparation method of the composition containing cyclic adenosine monophosphate is as follows:

[0027] Grind cyclic adenosine monophosphate, diphenhydramine, vinpocetine and nicotinic acid respectively and pass through a 100-mesh sieve, mix them according to the dosage of the formula, and then put them in an oven at 55-60°C for 30 minutes to prepare The composition containing cyclic adenosine monophosphate of this embodiment.

Embodiment 2

[0029] The composition containing cyclic adenosine monophosphate of the present invention, the formula of this composition is made up of each component of following parts by weight:

[0030]

[0031] The preparation method of the composition containing cyclic adenosine monophosphate is as follows:

[0032] Grind cyclic adenosine monophosphate, diphenhydramine, vinpocetine and nicotinic acid respectively and pass through a 100-mesh sieve, mix them according to the dosage of the formula, and then put them in an oven at 55-60°C for 30 minutes to prepare The composition containing cyclic adenosine monophosphate of this embodiment.

Embodiment 3

[0034] The composition containing cyclic adenosine monophosphate of the present invention, the formula of this composition is made up of each component of following parts by weight:

[0035]

[0036] The preparation method of the composition containing cyclic adenosine monophosphate is as follows:

[0037] Grind cyclic adenosine monophosphate, diphenhydramine, vinpocetine and nicotinic acid respectively and pass through a 100-mesh sieve, mix them according to the dosage of the formula, and then put them in an oven at 55-60°C for 30 minutes to prepare The composition containing cyclic adenosine monophosphate of this embodiment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a cyclic adenosine monophosphate-containing composition and applications thereof. According to the formula, the composition is prepared from the following components in parts by weight: 10-12 parts of cyclic adenosine monophosphate, 6-9 parts of diphenhydramine, 5-8 parts of vinpocetine and 2-3 parts of nicotinic acid. The cyclic adenosine monophosphate-containing composition has a good treatment effect on myocardial infarction by virtue of the combination of cyclic adenosine monophosphate, diphenhydramine, vinpocetine and nicotinic acid.

Description

technical field [0001] The invention relates to the technical field of new drug development, in particular to the development of drugs for treating myocardial infarction, and in particular to a composition containing cyclic adenosine monophosphate and its application. Background technique [0002] Myocardial infarction is acute necrosis of the coronary artery caused by acute and persistent hypoxia-ischemia. Due to the change of modern people's living habits and the emergence of problems such as the acceleration of the pace of life, the incidence of myocardial infarction in my country has shown an obvious upward trend in recent years, with at least 500,000 new cases every year and at least 2 million existing cases. Therefore, we are committed to developing new Drugs for the treatment of myocardial infarction with good effect have very important significance and broad market prospects. [0003] Cyclic adenosine monophosphate, the chemical name is 6-amino-9-β-D-ribofuranosyl-9H...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7076A61P9/10A61K31/455A61K31/4375A61K31/135
Inventor 李捍雄
Owner GUANGZHOU YIPINHONG PHARMA